Aegerion Pharmaceuticals (AEGR) was a big mover last session, as its shares rose over 5% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company as the stock is now down roughly 19% in the past one-month time frame.
The company has seen 2 negative revisions in the last seven days and its Zacks Consensus Estimate also moved lower over the same time frame, signaling trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday’s rise lasts.
Aegerion Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Some better-ranked biotechnology stocks include Heska Corp. (HSKA), AMAG Pharmaceuticals, Inc. (AMAG) and Actelion Ltd. (ALIOF). While Heska and Actelion carry a Zacks Rank #1 (Strong Buy), AMAG holds a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
AEGERION PHARMACEUTICALS INC (AEGR): Free Stock Analysis Report
AMAG PHARMACEUTICALS INC (AMAG): Free Stock Analysis Report
HESKA CORP (HSKA): Free Stock Analysis Report
ACTELION LTD (ALIOF): Free Stock Analysis Report
Zacks Investment Research
- Finance Trading
- Health Care Industry